Forgot password?
Sign up today and your first download is free.


March 28, 2017 | Daily News

President Donald Trump calls for slashing funding for Medicare counselors in fiscal 2017 as part of $18 billion in proposed spending cuts for the rest of the fiscal year, which also include $50 million in savings from making CMS more efficient, according to a budget document obtained by Inside Washington Publishers.

March 28, 2017 | Daily News

The Trump administration is proposing a $40 million cut in FDA appropriations for the remainder of fiscal 2017, driven primarily by reductions in staffing, according to a document obtained by Inside Washington Publishers, which was recently sent to congressional appropriators.

March 16, 2017 | Daily News

President Donald Trump's budget blueprint sparked concerns among multiple stakeholders and legislators Thursday (March 16) for putting stable appropriations funding and already-negotiated FDA user fee agreements at risk.

March 16, 2017 | Daily News

President Donald Trump's “skinny budget” for fiscal 2018 pumps more money into efforts to stem Medicare and Medicaid waste, fraud and abuse, but also signals possible changes to Medicare, Medicaid and the Children's Health Insurance Program by saying agency resources should be focused on the “highest priority activities” necessary to keep the programs running efficiently.

March 16, 2017 | Daily News

President Donald Trump’s proposed budget blueprint calls for industry to double up on user fees to fully pay for FDA premarket approvals in exchange for administrative reforms aimed at speeding products to market.

March 16, 2017 | Daily News

President Donald Trump’s proposed budget blueprint calls for industry to double up on user fees to fully pay for FDA premarket approvals in exchange for administrative reforms aimed at speeding products to market.

March 16, 2017 | Daily News

President Donald Trump proposes to slash National Institutes of Health funding by $5.8 billion in fiscal 2018, which if approved by Congress would deal a major blow to the bipartisan effort to bolster NIH through the recently enacted 21st Century Cures Act.

February 27, 2017 | Daily News

Non-defense federal agencies will be cut a total of $54 billion as part of President Donald Trump's proposed discretionary budget to offset new military spending the White House said Monday (Feb. 27), a cut if applied equally across agencies could render FDA incapable of fulfilling its responsibilities, a longtime FDA observer told Inside Health Policy.

February 27, 2017 | Daily News

An alliance of drug companies and research advocacy groups is calling for Congress to appropriate $2.8 billion for FDA in fiscal 2018 -- a $78 million increase from fiscal 2016.

February 23, 2017 | Daily News

The Committee for a Responsible Federal Budget says President Donald Trump should propose Medicare and Social Security reforms in his “skinny budget” that is expected soon.

February 10, 2017 | Daily News

Republicans have vowed to keep consumer protections in the Affordable Care Act that cover people regardless of their health status and allow children to stay on their parent’s plan until age 26, but there has been some chatter that the provision could be stripped or altered in an effort to get more young, healthy adults to enroll in the exchanges.

February 02, 2017 | Daily News

Democrats blasted Republicans over several draft reform bills that would stabilize the marketplace saying the reforms are incomplete and would take the health care system back to the way it was before the Affordable Care Act, especially if Republicans move forward with repealing the health care law.

January 09, 2017 | Daily News

HHS Secretary Sylvia Burwell, in a cabinet exit memo, said there's a need for the next administration to hike FDA's funding, stressing a need to improve regulatory science, stem antibiotic resistance and create a “robust” agency that could help improve competition in the pharmaceutical marketplace and in turn enable safe and affordable drugs.

December 29, 2016 | Daily News

FDA’s efforts to fill 1,000 vacancies at the agency, boosted by provisions in the 21st Century Cures Act, could be jeopardized by President-elect Donald Trump’s proposed federal government hiring freeze, warned Steven Grossman, deputy executive director of the Alliance for a Stronger FDA.

December 01, 2016 | Daily News

Republican Rep. Tom Price (GA), tapped to serve as HHS secretary in the incoming administration, is pushing for two-year budget cycles, a repeal of pay-as-you-go and a required notice and comment process on all significant guidance documents in a draft rewrite of the congressional budget process.

September 27, 2016 | Daily News

The Senate failed Tuesday (Sept. 27) to advance a temporary government spending bill introduced by Senate Majority Leader Mitch McConnell (R-KY) that would fund Zika vaccine development and mosquito control, as well as provide resources for the opioid bill signed into law earlier this year.

August 15, 2016 | Daily News

Democratic presidential nominee Hillary Clinton announced that if elected she would call on Vice President Joe Biden to continue his work on “Project Moonshot,” and urge Congress to approve funding for the initiative.

July 07, 2016 | Daily News

House Appropriations health subcommittee Republicans on Thursday (July 7) blocked Democrats’ amendments to restore funding that the chamber's HHS-spending bill would eliminate, such as money for Obamacare programs, comparative-effectiveness research and family planning programs.

July 06, 2016 | Daily News

The House Appropriations Labor-HHS subcommittee on Thursday (July 7) will consider a $161.6 billion draft appropriations bill that includes $73.2 billion for HHS but cuts prior-year mandatory funds for the Affordable Care Act and freezes new discretionary spending used to run the law.

June 27, 2016 | Daily News

Six former FDA commissioners over the weekend expressed support for making the FDA an independent agency, citing concerns with accessibility to the president, the affects of micromanagement on the agency and the “political maze” regulatory decisions currently need to navigate that keep FDA from taking important actions.